Time Horizon

12-36 months for the first binary catalysts. 5-7 years to commercial revenue. The catalyst calendar is sparse and back-loaded: NRC construction permit decision (Q1 2027), TX-1 fuel facility operations (H1 2028), first reactor commercial operation (early 2030s). Between now and Q1 2027, XE trades on thematic sentiment and IPO momentum, not fundamentals. The relevant analysis horizon is the lock-up expiration (~October 2026) and NRC CPA decision (Q1 2027) as the first two testable events.

Base Rate

Reference class: pre-revenue deep-tech IPOs at >$5B market cap, >100x trailing revenue.

Base rate: pre-revenue >$5B IPO → 3yr outperformance vs index ≈ 25-30%
Prior odds: 0.36

The base rate for companies IPO'ing above 100x non-commercial revenue generating positive 3-year returns relative to index is poor. The subset that succeed tend to have (a) a clear path to monopolistic market position, (b) a compressing timeline to first commercial revenue, and (c) capital sufficiency through commercialization. XE has an argument for (a) via regulatory moat and fuel lock-in, a contested argument for (b) given nuclear FOAK timelines, and explicitly fails (c) -- management states continued existence depends on additional capital.

A second reference class matters: nuclear first-of-a-kind projects reaching commercial operation on time and on budget. The base rate is approximately zero. Vogtle: 7 years late, $16B per unit. PBMR (XE's technology ancestor): cancelled after $1.5B without building a reactor. NuScale Idaho: cancelled after NRC design certification. China's HTR-PM: program launched 2001, full power 2023 (22 years). The sole exception in recent history is South Korea's Barakah project in the UAE (4 units, APR1400, delivered roughly on budget) -- and XE's Korean supply chain partners (Doosan, KHNP, DL E&C) were central to that project.

Alpha vs Beta

Total return attribution (structural expectation):
  Nuclear SMR thematic:     40-50% of variance
  AI/datacenter power:      10-20% of variance
  Market (SPY) beta:        10-15% of variance
  Growth/momentum style:    5-10% of variance
  Idiosyncratic:            15-30% of variance

  Edge in thematic:         ZERO (consensus trade, 15x oversubscribed)
  Edge in market/style:     ZERO
  Edge in idiosyncratic:    ZERO (no information advantage Day 2 of IPO)

Cannot run regression (2 days of data). Structural expectation based on peer decomposition: BWXT (established nuclear, $2.6B revenue) shows 40% idiosyncratic variance; pre-revenue SMR peers (OKLO, SMR, NNE) show 90%+ measured idio that is misleading -- binary event variance in pre-revenue names masquerades as idiosyncratic when it is actually thematic concentration. On days when "nuclear narrative" moves (policy announcements, peer catalysts, AI power demand news), these names move together. As XE accumulates data and the thematic factor crystallizes, expect idio share to compress toward 30-50%. This fails the 75% idio target. XE is a sector bet, not a stock pick.

---

B -- Business Model

X-Energy designs advanced nuclear reactors and manufactures proprietary nuclear fuel. It does not build, own, or operate reactors. Founded 2009 by Dr. Kamal Ghaffarian. Headquartered in Rockville, MD. 916 employees as of March 2026.

Product 1: Xe-100 Reactor (IP License)

The Xe-100 is a Generation IV high-temperature gas-cooled reactor (HTGR). Pebble-bed design. 80 MWe / 200 MWt per unit, deployed as 4-reactor "plants" producing 320 MWe. XE licenses the reactor IP and provides engineering, procurement, licensing support, and ongoing services. It does not take construction or operating risk directly.

How it works. The reactor core is a cylinder packed with approximately 220,000 tennis-ball-sized graphite pebbles, each containing ≈18,000 TRISO fuel particles. Helium gas -- inert, single-phase, chemically non-reactive -- flows through the spaces between pebbles, absorbs heat from fission, exits at 750C, and drives a steam generator to produce 565C steam for a conventional Rankine turbine (electricity) or direct industrial process heat (chemical production, hydrogen, petroleum refining).

Xe-100 vs conventional light-water reactor:

Parameter	Xe-100	AP1000 (Westinghouse)
Thermal output	200 MWt	3,400 MWt
Electric output	80 MWe	1,117 MWe
Thermal efficiency	≈40%	≈33%
Coolant	Helium gas (single-phase, inert)	Pressurized water (phase-change risk)
Moderator	Graphite	Water
Fuel	TRISO pebbles (HALEU 15.5%)	UO2 pellets (LEU <5%)
Coolant outlet temp	750C	≈325C
Operating pressure	≈60 bar	≈155 bar
Refueling	Online (continuous)	Offline (18-24 month cycles)
Emergency planning zone	400 meters	16 kilometers
Capacity factor target	95%+	90-93%
Design life	60+ years	40-60 years

Why helium coolant matters.

1. Single-phase: Helium never changes phase. Water-cooled reactors face catastrophic steam generation during loss-of-coolant accidents -- this is what happened at Fukushima and Three Mile Island. Helium cannot flash to steam.
2. Chemical inertness: Noble gas. Does not corrode piping, does not react with fuel, does not activate to create radioactive byproducts (unlike water, which creates tritium).
3. High temperature: 750C outlet enables higher thermal efficiency (≈40% vs ≈33% for LWR) and industrial process heat applications. LWRs top out at ≈325C -- too cool for most industrial heat demands (hydrogen production, chemical manufacturing, petroleum refining).
4. Transparent: Visual inspection of reactor internals is possible during maintenance.
5. Downside: Helium is a poor heat transfer medium compared to water (lower density, lower heat capacity per unit volume). This is why the reactor is only 80 MWe -- power density cannot scale as high as with water cooling. The 4-pack configuration (320 MWe) is the practical deployment unit.

Why 80 MWe (small) is a feature, not a limitation. Traditional nuclear's problem is size. An AP1000 produces 1,117 MWe, costs $16B+, and takes 10+ years to build. One unit, one failure point, one massive capital commitment. The Xe-100 at 80 MWe x 4 = 320 MWe enables:

• Modular construction: Factory-built reactor modules shipped to site, not poured-in-place concrete.
• Incremental deployment: Build one reactor, commission it, build three more. Not bet-the-farm on a single GW-scale unit.
• Redundancy: If one of four reactors is offline, 240 MWe (75% capacity) remains. An AP1000 offline means zero output.
• Right-sized for end markets: Data centers need 300-1,000 MWe. Industrial sites need 200-500 MWe. Behind-the-meter deployment requires smaller units.
• Load following: Xe-100 can ramp from 100% to 40% output and back in minutes. Traditional nuclear operates baseload-only. Data centers and industrial processes need load-following capability.

Why the Xe-100 cannot melt down -- three independent physics mechanisms:

1. Negative temperature coefficient of reactivity. As fuel temperature rises, neutron absorption increases (Doppler broadening of U-238 resonances), the fission rate drops, and power decreases automatically. This is physics, not engineering -- it works even with all systems failed, all operators absent, all power lost. The hotter the core gets, the more it slows itself down. LWRs also have negative temperature coefficients, but with a critical difference: LWR fuel (UO2 pellets in zirconium cladding) melts at ≈2,800C, and at high temperatures the zirconium-water reaction produces hydrogen (explosion risk -- this caused the Fukushima hydrogen explosions). TRISO fuel survives above 1,600C without releasing fission products, and there is no water to react with.

2. Low power density. 200 MWt in a physically large core means low power per unit volume. After shutdown, decay heat is small enough to dissipate passively through conduction and radiation to the environment. No pumps, no water, no backup power required. Contrast with an LWR: 3,400 MWt in a compact core = massive power density = massive decay heat = active cooling MUST continue post-shutdown (emergency core cooling systems, diesel generators, etc.). Fukushima failed because tsunami-flooded diesel generators could not provide active cooling.

3. TRISO fuel containment. Each TRISO particle is its own containment vessel. The silicon carbide shell retains fission products up to 1,600C+. The maximum calculated accident temperature for the Xe-100 core (total loss of coolant plus total loss of power) stays below 1,600C. The fuel physically cannot reach temperatures where fission products escape, even in the worst possible accident scenario. There is no need for a massive reinforced concrete containment building because the containment is at the particle level, multiplied 220,000 x 18,000 = ≈4 billion individual containment vessels across the core.

Net effect: Emergency planning zone of 400 meters (vs 16 km for LWR). This is the NRC's acknowledgment that accident consequences are fundamentally different in kind. A smaller EPZ means reactors can be sited behind the meter at data centers and industrial plants -- enabling the business model.

Online refueling. LWRs refuel every 18-24 months by shutting down for 2-4 weeks: drain coolant, open the pressure vessel, replace one-third of fuel assemblies, reassemble, pressure test, restart. Lost generation = lost revenue. The Xe-100 uses continuous online refueling: fresh pebbles are added at the top of the core while spent pebbles are removed from the bottom during operation. Each pebble makes approximately 6-10 passes through the core over its lifetime (burnup is measured on extraction, and the pebble is either recycled for another pass or discharged as spent fuel). No shutdown required. This drives the 95%+ capacity factor target and eliminates refueling outage costs. Over a 60-year reactor life, 95% vs 90% capacity factor is roughly 3 additional equivalent years of full-power generation.

Design maturity:

Stage	Status
Conceptual design	Complete (2017-2019)
Preliminary design	Substantially complete
Detailed design	In progress (60% design review for TX-1 complete, 90% starting May 2026)
NRC pre-application engagement	Complete (began 2018)
Construction Permit Application (Dow)	Filed March 2025, docketed May 2025, under 18-month review
Standard Design Approval	Not yet filed (would enable broader deployment without per-customer CPAs)
First reactor operation	Target early 2030s

No Xe-100 has ever been built. The design exists in engineering documents and simulation. HTGR technology has been demonstrated at various scales (Peach Bottom USA 1960s, Dragon UK 1960s, AVR Germany 1960s-80s, THTR-300 Germany 1980s, HTR-PM China 2021-present), but the Xe-100 specific design, at this specific power level, in this specific configuration, with this specific fuel form, manufactured at this specific facility, has never been tested as an integrated system. This is the fundamental FOAK risk.

Product 2: TRISO-X Pebble Fuel (Manufacturing)

TRISO = TRi-structural ISOtropic. A fuel particle design where uranium fuel kernels are individually coated in multiple ceramic layers, then embedded in a graphite matrix to form spherical pebbles approximately 6 cm in diameter (tennis-ball-sized).

Fuel particle structure (inside to outside):

1. UCO Kernel (uranium oxycarbide)
   - HALEU enriched to 15.5% U-235
   - ≈0.5 mm diameter
   - Where fission occurs

2. Porous carbon buffer layer
   - Absorbs fission product gases
   - Accommodates kernel swelling from sustained fission

3. Inner pyrolytic carbon (IPyC)
   - Dense carbon barrier
   - Structural support for SiC layer

4. Silicon carbide (SiC) shell  ← THE critical barrier
   - ≈35 micrometers thick
   - Refractory ceramic, melting point >2,700C
   - Retains fission products up to 1,600C+
   - Each particle is its own pressure vessel / containment
   - DOE calls TRISO "the most robust nuclear fuel on Earth"

5. Outer pyrolytic carbon (OPyC)
   - Protects SiC during manufacturing and handling
   - Additional fission product barrier

6. Graphite matrix
   - ≈18,000 coated particles embedded per sphere
   - Final pebble is ≈6 cm diameter
   - Withstands temperatures above 1,600C without releasing fission products

Why the SiC layer is the investment thesis in miniature. Silicon carbide is a refractory ceramic. It melts above 2,700C. The maximum accident temperature for the Xe-100 core is calculated to stay below 1,600C even in total loss-of-coolant-plus-total-loss-of-power scenarios. This means the fuel physically cannot reach temperatures where fission products escape the SiC shell. Compare to traditional LWR fuel: UO2 pellets in zirconium alloy cladding, where the cladding fails at ≈1,200C and the zirconium-water reaction at high temperature generates hydrogen (the mechanism behind Fukushima's explosions). TRISO fuel has no water to react with, no cladding to melt, no hydrogen generation pathway. The containment is inherent to the fuel design itself.

HALEU enrichment -- the supply chain challenge. Conventional nuclear fuel uses low-enriched uranium (LEU) at less than 5% U-235 enrichment. TRISO-X fuel uses High-Assay Low-Enriched Uranium (HALEU) at 15.5% enrichment. Higher enrichment means higher energy density, a smaller core, and fewer fuel pebbles needed. But it also creates three problems:

1. More enrichment work required: 15.5% vs <5% requires approximately 3x the separative work units (SWU). More centrifuge passes through the cascade, more expensive per kilogram.
2. Category II nuclear material security: HALEU above 10% enrichment requires Category II physical security (vs Category III for LEU below 10%). More expensive to handle, store, and transport. This is why TX-1 needed a specific NRC Special Nuclear Material License -- the first of its kind in the US.
3. No commercial supply chain exists: Current global enrichment infrastructure is optimized for <5% LEU. HALEU production at 15.5% requires either modifying existing centrifuge cascades or building new dedicated ones. Only Centrus Energy (Piketon, OH) is producing HALEU in the United States, at a pilot scale of approximately 1 metric ton of uranium per year. Russia and China have HALEU production capacity but are geopolitically excluded from the US supply chain.

The HALEU math -- supply vs demand:

Item	Quantity
Current US HALEU production (Centrus pilot)	≈1 MTU/yr
Centrus target by Q1 2029	6 MTU/yr
Urenco (UK) target	≈10 MTU/yr by ≈2031
DOE allocated to XE	7.6 MTU total (enough for first Dow plant initial load)
TX-1 throughput requirement	5 MTU/yr (serves 11 reactors at steady state)
TX-2 throughput requirement	20 MTU/yr (serves 44 reactors at steady state)
Combined TX-1 + TX-2	25 MTU/yr
144-reactor pipeline cumulative need	>>100 MTU (initial loads + ongoing refueling)

Even at the most optimistic 2029-2031 supply targets, total global non-Russia/China HALEU production may be 15-25 MTU/yr -- and XE is not the only customer. The DOE has allocated $3.4B in Congressional appropriations plus $2.7B in additional enrichment awards to address this, but centrifuge cascades take years to design, build, license, and commission. This is a physics constraint on XE's scaling, not a business constraint. The enriched uranium supply chain determines how fast this company can grow regardless of customer demand, reactor design readiness, or NRC approvals.

Fuel qualification status. NRC must approve that the fuel performs as designed under irradiation conditions representative of reactor operation. This requires fabricating fuel to specification, irradiating it in a test reactor (years of exposure), performing post-irradiation examination, and demonstrating that fission product retention meets safety analysis assumptions.

XE's fuel qualification methodology has been approved by the NRC. It leverages the DOE's Advanced Gas Reactor (AGR) Fuel Development Program -- decades of TRISO irradiation test data -- as the qualification basis. XE is currently in the "final stages of qualifying our TRISO-X pebble fuel" (S-1, p.9), meaning irradiation tests are underway. The pilot facility at Oak Ridge has produced kilogram batch quantities since 2016-2018. If irradiation tests reveal unexpected fuel failure modes (particle coating defects, kernel swelling, SiC cracking), fuel qualification fails and the entire timeline resets. This has happened historically with early TRISO fuel, which had quality control issues.

XE's proprietary fabrication process. The TRISO fuel concept is decades old and public domain. What XE claims as proprietary is the commercial-scale manufacturing process -- the specific methods for coating TRISO particles with consistent quality at production volumes, and embedding them uniformly into graphite pebbles. Germany's AVR and THTR reactors in the 1970s-80s experienced pebble fuel quality issues (broken pebbles, inconsistent coatings). The DOE AGR program in the 2000s-2010s systematically addressed these through improved manufacturing controls. XE builds on this foundation.

The distinction between patent and trade secret matters for the Bayh-Dole question. Patents on ARDP-funded inventions are subject to government march-in rights. Trade secrets in the manufacturing process (know-how, process parameters, quality control recipes) are NOT necessarily subject to march-in. XE's real moat may be in the manufacturing know-how, not the patent claims.

Product 3: XENITH Microreactor (Early Stage)

5-10 MWe HTGR microreactor for military, defense, and remote applications. Uses TRISO compacts (pressed fuel forms, not pebbles). 750C operating temperature. 20-year life without refueling. DOD Project Pele funded approximately $60M across three awards (2020-2023). Period of performance has expired. Early-stage, not operational. Not material to the investment thesis. Option value only.

Technology Heritage -- Not Vaporware, Not Proven

HTGR is the oldest advanced reactor concept. This is not a startup idea:

Year	Program	Details	Outcome
1966	Peach Bottom (US)	40 MWe HTGR, Pennsylvania	Operated successfully, decommissioned 1974
1966-76	Dragon (UK)	HTGR, 20 MWt	Operated, decommissioned
1967-88	AVR (Germany)	46 MWt pebble-bed	Operated 21 years, technology ancestor
1985-89	THTR-300 (Germany)	300 MWe pebble-bed	Shut down -- pebble breakage issues
2000-10	PBMR (South Africa)	Pebble-bed commercial reactor	Cancelled after $1.5B, never built
2012-14	XE hires PBMR scientists	van Staden, Mulder join XE	Technology transfer
2001-23	HTR-PM (China)	2x 250 MWt pebble-bed, 210 MWe	World's first commercial pebble-bed HTGR, full power Dec 2023

The technology lineage is: German AVR → South African PBMR → X-Energy Xe-100. The uncomfortable precedent is that the direct technology ancestor (PBMR) was cancelled after $1.5B without building a reactor. The engineering was real. The economics did not work in South Africa's context. China did build their version -- but with state-backed construction capability and cost structure the US does not replicate.

Revenue Model

Three revenue streams per reactor deployment:

1. Technology licensing fees (one-time): XE licenses the Xe-100 reactor IP to the project developer/owner. No specific fee disclosed. Estimated at 3-5% of plant construction cost ($3-5B for a 4-pack), implying $100-200M per deployment.

2. Development and construction services (over 5-7 year build period): Engineering, procurement support, regulatory licensing assistance, construction oversight. This is what currently generates revenue (DOE ARDP and Dow project services). Estimated $80-150M per deployment based on current services revenue run rate and project scope.

3. Fuel fabrication (recurring over 60-year reactor life): Initial fuel load plus ongoing refueling. The Xe-100 is designed exclusively for TRISO-X fuel -- the reactor cannot use any alternative fuel without fundamental redesign. This creates a captive customer relationship for 60 years per reactor. Estimated $15-30M per 4-pack per year for refueling (initial load higher). This is the real long-term value -- an annuity stream that scales linearly with the number of deployed reactors.

Revenue per 4-pack deployment (estimated, no disclosure):

Stream	Estimate	Basis
Technology licensing fee	$100-200M	3-5% of $3-5B plant cost
Development + construction services	$80-150M	5-7 year engagement
Initial fuel load	$30-60M	Rough, based on fuel fabrication cost estimates
Total one-time per 4-pack	$210-410M
Annual fuel refueling (recurring)	$15-30M/yr	Per 4-pack, for 60 years

These are estimates. No per-reactor pricing, margin, or unit economics have been disclosed anywhere in the S-1. Management explicitly warns that "illustrative capacity figures and unit economics" are "estimates based on numerous assumptions" that "may differ materially, including lower pre- and post-COD revenues and margins."

Customer Contracts -- Full Detail

Dow Chemical (Seadrift, TX) -- Anchor Customer, FOAK Project

Dow subsidiary holds the NRC Construction Permit Application for a 4-reactor Xe-100 plant (320 MWe) at Dow's Seadrift, TX manufacturing site. This is XE's most advanced project and the FOAK reactor deployment.

Structure: XE has a Master Project Development Agreement (MPDA) and Construction Completion Agreement (CCA) with Dow. The project is backed by DOE ARDP cost-sharing ($1.2B total commitment, 50% of $2.4B eligible costs).

Timeline: CPA filed March 2025, docketed May 2025 with 18-month NRC review. CPA decision expected Q1 2027. If approved, construction begins, targeting commercial operation in the early 2030s.

The critical contract term: Dow can terminate the MPDA and CCA "at any time for convenience without regard for our performance" (S-1, p.28, q=0.95). This is not a standard termination-for-cause provision. Dow can walk away for any reason, at any time, at any stage of the project.

The ARDP funding cliff: ARDP's current budget period runs through August 2026, with extensions at DOE's discretion. The maximum performance period is 10 years from February 2021 = 2031. The Dow project's construction timeline extends beyond the ARDP period -- meaning post-2031 construction costs would fall entirely on Dow. If Dow is unwilling to bear 100% of remaining costs, the project terminates. Dow (DOW) is a $43B-revenue investment-grade company with $2-3B annual capex. The Seadrift project ($2-5B total cost) is material to Dow's capital allocation but not existential. The strategic rationale is decarbonization of industrial operations, but Dow's termination-for-convenience right means commitment is revocable at any stage.

ARDP funding detail: $1.2B total commitment. $438M reimbursed as of December 31, 2025. $662M remaining. An additional $3.1B has been appropriated to ARDP broadly; "some portion" is expected for XE but not guaranteed. DOE can cancel the ARDP contract at any time without substantive penalty.

Amazon / Energy Northwest (Richland, WA) -- Largest Pipeline Customer

Amazon invested directly in XE (24.9% economic interest) and in the Energy Northwest project. Energy Northwest is a public power entity in Washington state that owns and operates the Columbia Generating Station, a 1.2 GWe nuclear plant. The XE project would be sited at the Columbia site in Richland, WA.

Phase 1: 4 reactors (320 MWe), with potential upsize to 12 reactors (960 MWe). Power available to Amazon AND northwest utilities (up to 50% of output to public power). CPA submission to NRC targeted by end 2026. NRC construction permit expected 2028. Site construction starting H1 2028. Commercial operation early 2030s.

Full pipeline: Options for more than 5 GWe of Xe-100 deployments by 2039 -- equivalent to 62+ reactors. This is XE's largest customer pipeline by a wide margin.

Amazon's contract terms (S-1, p.29, q=0.95):

1. First-priority manufacturing queue slots from 2031 through 2039 at TX-1 and TX-2. Amazon gets fuel before anyone else.
2. Right of first refusal (ROFR) on XE's delivery schedule. Amazon can claim delivery slots ahead of other customers.
3. Most-favored-nation (MFN) pricing. XE must offer Amazon terms at least as favorable as any other customer. If XE gives Dow better pricing, Amazon gets it too.
4. Cost efficiency sharing. As XE's production costs decline (learning curve, NOAK improvements), XE must share the savings with Amazon. Amazon benefits from XE getting cheaper without doing anything.
5. Queue constraints limit serving higher-margin customers. Amazon's priority slots restrict XE's ability to serve other customers who might pay more.

These terms give Amazon optionality without obligation and capture economic surplus from XE. Amazon can exercise options when convenient and walk away when not. XE has obligation (priority manufacturing, pricing constraints) without reciprocal commitment. This is classic monopsony dynamics -- a single dominant buyer extracting favorable terms from a supplier with limited alternatives.

Amazon's alternative power strategies include nuclear restarts (Three Mile Island / Talen), natural gas, renewables, and potentially other SMR technologies. The 5+ GWe pipeline with XE is one of multiple power sourcing approaches. Amazon has no contractual obligation to purchase any reactors.

Centrica (UK) -- International Pipeline

Joint Development Agreement (JDA) for UK deployments targeting approximately 6 GWe (76 reactors). Explicitly non-binding (S-1, p.29, q=0.95). UK regulatory approval pathway is separate from NRC -- Centrica/XE would need approval from the UK Office for Nuclear Regulation, which has its own multi-year process. Timeline is mid-2030s at the earliest. Centrica has exit ramps at every stage.

Other Pipeline:

• OPG (Ontario Power Generation): Exclusive framework for Ontario deployments. OPG is an equity investor. Non-binding framework.
• Talen Energy: Non-binding LOI for nuclear power at Talen sites.
• IHI Corp (Japan): MOU signed March 2026 for nuclear-grade reactor components. Explicitly non-binding -- "parties have not entered into binding agreements" (S-1, p.12).
• DL E&C: Korean EPC contractor, equity investor, global opportunities. No binding project contract.

Supply Chain Partners -- Detail

Doosan Enerbility (Korea). Manufacturer of nuclear-grade heavy equipment. Has manufactured 34 reactor pressure vessels and 124 steam generators globally. Signed a Reservation Agreement in December 2025 committing to build a new SMR fabrication facility specifically for XE reactor components. Equity investor. This is not an MOU -- a reservation agreement represents committed capital expenditure to build manufacturing capability.

KHNP (Korea Hydro & Nuclear Power). Korean state utility. Has built 30 nuclear plants -- 26 in Korea, 4 in the UAE (Barakah project, APR1400 reactors). Barakah is the only recent nuclear construction project delivered roughly on time and on budget. In August 2025, KHNP signed a compact with XE, Amazon, and Doosan for Amazon order book deployment in the US. KHNP's involvement brings the only demonstrated recent track record of on-schedule nuclear construction.

SGL Carbon. 10-year graphite supply agreement with XE. $100M+ initial 3-year award. Production has commenced for the Dow Seadrift project -- material is being manufactured. This is the first supply chain commitment where atoms are actually moving.

Curtiss-Wright. Nuclear systems supplier. Preferred strategic supplier for Xe-100 components after competitive bid process. Equity investor.

IHI Corp (Japan). MOU signed March 2026 for nuclear-grade components. Non-binding.

DL E&C (Korea). Korean EPC contractor. Equity investor. No binding project contract.

Assessment: The Korean supply chain (Doosan, KHNP, DL E&C) is genuinely strong. Korea is the only country that has delivered nuclear construction on time and on budget in recent decades. Doosan's commitment to build a dedicated fabrication facility and KHNP's compact for Amazon deployment represent real capital and institutional commitment, not just letters of intent. SGL Carbon's graphite production for Dow is the first material supply chain execution. This supply chain is more substantive than the typical pre-revenue company's "strategic partnerships."

TX-1 and TX-2 Fuel Fabrication Facilities

TX-1 (under construction, Oak Ridge, TN):

• 214,000 square feet
• 5 MTU/yr HALEU throughput
• ≈700,000 TRISO-X pebbles per year
• Capacity to fuel 11 Xe-100 reactors at steady state
• SNM License received February 2026 -- first-ever Category II nuclear fuel facility in the United States (40-year license)
• Site prep substantially complete
• Clark Construction began vertical build September 2025
• Phase 2B starting mid-2026
• 60% Design Review complete
• 90% Design Review starting May 2026
• Target completion 2027, operations H1 2028
• DOE $150M tax credit (milestone-based, incentivizes on-schedule delivery)

TX-2 (planning stage, adjacent to TX-1):

• 25 MTU/yr total capacity (20 MTU throughput)
• ≈2,800,000 pebbles per year
• Capacity to fuel 44 reactors per year
• Planned adjacent to TX-1 on the same property
• Would NOT require a separate NRC license if built on the same site (confirmed in S-1) -- this removes a major scaling bottleneck
• No timeline disclosed for construction start

Combined capacity: 30 MTU/yr, 3,500,000 pebbles/yr, 55 reactors served. The pipeline of 144 reactors would require approximately 3x TX-2-equivalent capacity.

The fuel annuity math: Each reactor operates for 60 years. At 11 reactors per TX-1 year of production, after 4 years of production, 44 reactors need ongoing refueling. By year 10, 100+ reactors need TRISO-X fuel -- recurring revenue scales linearly with the deployed reactor base. This IS the genuinely attractive long-term value of the business model. But it requires (1) reactors to be built and commissioned, (2) HALEU supply to exist at scale, and (3) TX-1/TX-2 to operate successfully. All three are 5-7+ years from materializing.

---

PHI -- Financial Trajectory

All figures from S-1/A filed April 20, 2026 (q=0.95). XE's fiscal year ends December 31.

Revenue: Declining, Not Commercial

	FY2025	FY2024	Change
Services revenue	$94.3M	$84.0M	+12%
Grant income	$14.8M	$36.2M	-59%
Total	$109.1M	$120.2M	-9%

Revenue composition (FY2025):

• DOE ARDP contract: $89.2M (82% of total revenue + grants). Of this, $74.4M is services revenue and $14.8M is grant income.
• Dow Seadrift project services: Declined $19.9M year-over-year. Work slowed after CPA submission to NRC (March 2025). This is a natural lull between licensing submission and construction start.
• Energy Northwest (Amazon project): +$3.4M, a new revenue stream beginning Q2 2024.
• DoD contract: -$5.3M YoY.

Revenue recognition warning: XE recognizes government contract revenue using the ASC 606 cost-to-cost input method (S-1, p.109). This means revenue is recognized proportional to costs incurred relative to total estimated project costs. The economic implication: as XE ramps spending on ARDP work, "revenue" increases mechanically because spending IS the revenue recognition trigger. Investors should understand that services revenue growth reflects increased expenditure on government work, not commercial traction or customer demand. If XE spends $200M next year on ARDP activities, it will recognize roughly $200M in revenue (offset by the 50% cost-share structure). The appearance of "growth" is an artifact of the accounting method applied to a cost-reimbursement contract.

Margins: Deteriorating

	FY2025	FY2024
Gross margin (services rev - direct costs)	-71%	-55%
Operating margin	-156%	-103%
Operating loss	-$170.3M	-$123.5M

Direct cost breakdown (+$31.3M, +24% YoY):

• Direct labor: +$19.9M (headcount growth + bonuses)
• Subcontracting: +$6.7M
• Direct materials: +$6.6M (ARDP activity)

SG&A detail (requires adjustment): Headline SG&A increased only $4.4M (+4%) from $111.9M to $116.3M. But FY2024 included a one-time $55.3M cost for warrant issuance to Amazon. Stripping this out, underlying SG&A increased approximately $60M:

• Payroll: +$26.8M (headcount growth)
• Unit-based compensation: +$13.5M (new stock grants)
• Contractor costs: +$12.1M
• Technology costs: +$5.5M

Costs are growing roughly 2x the rate of revenue. This trajectory will continue as TX-1 construction ramps, headcount grows for commercialization, and public company overhead scales.

Pro forma public company costs: The S-1 shows pro forma operating loss of -$217M vs actual -$170M, a +$47M increment consisting of $17M incremental compensation and $30M incremental stock-based compensation. These costs are now permanent.

Cash Flow: Burn Accelerating

	FY2025	FY2024	Trend
Operating cash burn	-$149.9M	-$96.2M	+56%
Gross capex	-$117.2M	-$4.2M	+2,700%
DOE capex reimbursement	+$54.8M	+$2.3M
Net capex	-$62.4M	-$1.9M
Total cash consumption	-$212.3M	-$98.1M	+116%
Interest income (cash)	+$20.3M	+$2.8M	Partial offset
Net burn	≈$192M	≈$95M	Doubling

Capex detail: The $117.2M in gross capex is TX-1 fuel facility construction (Clark Construction vertical build, beginning September 2025). DOE reimbursed $54.8M under the ARDP cost-share agreement. Net capex of $62.4M represents XE's share of FOAK infrastructure buildout. DOE authorized an additional ≈$30M for early long-lead equipment procurement.

Interest income: $20.3M in FY2025 (from $2.8M prior year). The $1B+ post-IPO cash balance earns meaningful interest in money market and held-to-maturity securities. This partially offsets burn but does not change the trajectory.

"Other expense" of $239M: Mark-to-market loss on warrant liabilities ($223.5M), a non-cash charge. Warrants reclassified as liabilities under ASC 815. This inflates headline net loss but is non-operational. The pro forma financial statements strip this out. Investors should focus on operating loss (-$170M) and operating cash burn (-$150M) as the relevant metrics.

Burn rate projection:

	FY2024	FY2025	FY2026E
Operating cash burn	-$96M	-$150M	-$180-220M
Net capex	-$2M	-$62M	-$80-120M
Pro forma public co. costs	--	--	-$47M
Interest income	+$3M	+$20M	+$40-50M
Net burn	≈$95M	≈$192M	$250-340M

Management explicitly states: "management expects that future operating losses and negative operating cash flows may increase from historical levels" and "our continued existence is dependent upon our ability to obtain additional capital to support our ongoing operations" (S-1, p.106, q=0.95).

Balance Sheet: Clean but Finite

	Dec 31, 2025	Pro Forma Post-IPO
Cash	$458.9M	$1,152.8M
Short-term investments	$304.9M	$304.9M
Long-term investments	$261.5M	$261.5M
Total liquidity	$1,025.3M	$1,719.2M
Debt	≈$0	≈$0

Zero debt. All prior debt was settled or converted by end of FY2024. Clean balance sheet post-IPO.

Runway calculation:

• Post-IPO cash $1.15B / $300M midpoint FY2026E burn = 3.8 years
• Including $567M investments = 5.7 years
• But burn is accelerating, and TX-1 Phase 2B + reactor construction ramp will push costs higher
• Future dilutive equity raises are near-certain given management's explicit statement

What's Changing (Derivatives)

1. Burn rate doubling annually ($95M → $192M → $300M+)
2. Capex inflected from $4M to $117M as TX-1 construction ramps
3. Revenue source shifting -- Dow services declining (post-CPA lull), Energy Northwest ramping
4. Public company cost structure now permanent (+$47M/yr)
5. Grant income declining ($36M → $15M) and unpredictable going forward
6. Interest income growing ($3M → $20M → $40-50M) as cash balance earns returns

---

K -- Competitive Position

Moat Classification

Regulatory barrier (K_reg): STRONG. NRC licensing creates near-infinite entry cost for new reactor designs. The process takes years and hundreds of millions of dollars. XE's specific advantages within this barrier:

• CPA docketed with 18-month review timeline -- "one of the shortest CPA timelines ever given" (S-1, p.5, q=0.95)
• DOE ARDP selection as 1 of 2 advanced reactor demonstrations, providing $1.2B in government funding
• SNM License received February 2026 -- the first Category II nuclear fuel facility ever licensed in the United States, with a 40-year license term
• NRC pre-application engagement ongoing since 2018 (8 years of regulatory relationship)

This barrier is real, durable, and structural. New entrants cannot bypass it. The NRC licensing process is a multi-year institutional commitment that creates genuine lock-in.

Switching cost (K_switch): EXTREME post-deployment, ZERO pre-deployment. Once a reactor is built with TRISO-X fuel design, the operator is a captive customer for the reactor's full 60-year operating life. The reactor physically cannot use any alternative fuel without fundamental redesign. The switching cost components post-deployment: fuel supply lock-in (reactor accepts only TRISO-X pebbles), operator training (XE-specific procedures), maintenance contracts (XE components and expertise), regulatory compliance (NRC license tied to specific fuel type).

But: no customer has committed irreversibly. The switching cost moat activates ONLY after a reactor is built and fueled. Before that point:

• Dow can terminate for convenience at any time
• Amazon holds options, not obligations
• Centrica's JDA is non-binding
• No FID has been made for any project

The moat is enormous but latent. It does not protect XE today.

Manufacturing know-how (K_data): THE REAL MOAT. The TRISO fuel concept is 60 years old and in the public domain. China operates a TRISO fuel fabrication facility. What XE claims as proprietary is the commercial-scale manufacturing process -- the specific methods for coating TRISO particles with consistent quality at production throughput, and embedding them uniformly in graphite pebbles. Germany's early pebble-bed reactors experienced fuel quality issues (broken pebbles, inconsistent coatings). The DOE AGR program spent decades systematically addressing these quality control challenges.

XE's proprietary fabrication process is trade secret, not just patent. This distinction matters for the Bayh-Dole question: patents on ARDP-funded inventions are subject to government march-in rights, but trade secrets in manufacturing process know-how are not necessarily subject to the same constraint. The actual moat may survive government IP claims precisely because it lives in undisclosed manufacturing knowledge rather than patented design.

Scale advantage (K_scale): UNPROVEN. XE claims 30%+ NOAK (Nth-of-a-kind) cost reductions through repetitive manufacturing. Vogtle's learning curve (4th unit ≈20% cheaper than 3rd) provides a nuclear-specific precedent (S-1, p.6). Modular factory construction theoretically amplifies learning-curve benefits beyond site-built reactors.

But XE has delivered zero FOAKs. Every nuclear FOAK in history has overrun projected costs. The learning curve is theoretical until the first reactor is built. NOAK economics are contingent on building enough reactors to reach the learning curve -- which requires the pipeline to convert, which requires the fuel to exist, which requires HALEU supply.

Network effects (K_net): MINIMAL. No network effects in nuclear reactor design. The value of an Xe-100 deployment does not increase with the number of other deployments (beyond the indirect learning-curve effect on manufacturing costs).

Brand (K_brand): VALIDATION-DRIVEN. Brand value comes from DOE selection, Amazon backing, NRC engagement, and Korean supply chain partnerships. Not consumer-facing.

Bayh-Dole IP Constraint

DOE retains march-in rights on all ARDP-funded intellectual property (S-1, p.136, q=0.95):

• Nonexclusive, nontransferable, irrevocable, paid-up license for government's own benefit
• DOE can require XE to grant licenses to third parties in specified circumstances (e.g., if XE is not commercializing fast enough, or if broader access serves public interest)
• If XE refuses, the government can grant the license itself
• Government can cancel the ARDP contract at any time without substantive penalty
• XE will own the TX-1 facility subject to government property rights under 2 CFR 200.311

March-in rights have rarely been exercised historically across any federal program. But the right is disclosed and real. If a future administration decided that broader access to SMR technology served national interest (e.g., climate emergency, grid reliability crisis), the legal mechanism exists to force-license XE's reactor design IP to competitors.

International Competition

China already operates a commercial HTGR and has a TRISO fuel fabrication facility, marketing the technology internationally (S-1 Risk Factors, q=0.95). The HTR-PM at Shidao Bay (500 MWt, 2x 250 MWt reactors driving 210 MWe) reached full power in December 2023 -- the world's first commercial pebble-bed HTGR. China has demonstrated operating experience that XE does not have.

In NRC-licensed US markets, China's reactor design is irrelevant (not NRC-approved, and geopolitical tensions make future approval extremely unlikely). But in non-allied international markets (Middle East, Southeast Asia, Africa, parts of South America), China has first-mover advantage with proven technology, state-backed financing, and competitive construction costs. XE's international expansion via Centrica (UK) and other potential customers faces this directly.

Peer Comparison

	XE	OKLO	SMR (NuScale)	NNE	BWXT
Price (Apr 27)	$35.98	$75.93	$12.65	$25.76	$222.07
Market cap	$9.5B	≈$8B	≈$3B	≈$0.5B	$22B
Revenue	$109M*	≈$0	≈$50M*	≈$0	$2.6B
Operating loss	-$170M	~-$100M	~-$80M	~-$15M	+$390M
NRC status	CPA under review	Resubmitting (denied 2022)	Design cert received (Jan 2023)	Pre-application	N/A (supplier)
Reactors delivered	0	0	0	0	Many (components)
Customer pipeline	11+ GWe	Limited	None (Idaho cancelled)	Minimal	Navy + commercial
Beta	N/A (Day 2)	0.94	2.28	N/A	0.79
%Idiosyncratic	N/A	99.2%	96.7%	90.1%	40.0%
Short interest	N/A	18.8%	23.5%	21.4%	4.4%
1Y momentum	N/A	+210%	-25%	+8%	+106%

*Non-commercial development revenue

NuScale (SMR) has the most advanced NRC status (design certification received January 2023) but its anchor project (Idaho, with UAMPS) was cancelled. NuScale is pivoting to new customers but has none yet. The market punished this severely -- NuScale at $3B vs XE at $9.5B reflects the perceived value of Amazon as anchor customer and an intact pipeline.

OKLO at $8B with near-zero revenue and an NRC denial in 2022 (resubmitting) is a comparable valuation to XE. Both are pre-revenue, both trade on narrative.

BWXT at $22B with $2.6B revenue, actual nuclear components production, and Navy contracts is what "real nuclear revenue" looks like. XE would need $600M+ in commercial revenue to justify current market cap at BWXT-like multiples (≈15x revenue). That is 6x current non-commercial revenue and requires multiple reactors in commercial service.

---

G -- Governance

Ownership Structure

Holder	Class A	Class B	Economic	Voting
Dr. Kamal Ghaffarian (founder)	6.6M (2.5%)	84.2M (60.9%)	≈23%	≈35%
Amazon	65.8M (24.9%)	--	≈17%	≈17%
Ares Management	1.9M	36.2M (26.2%)	≈10%	≈10%
XERC Holdings (Ken Griffin/Citadel)	16.2M (6.1%)	--	≈4%	≈4%
Segra Capital	14.0M (5.3%)	--	≈4%	≈4%
Jane Street	0.6M	10.9M (7.9%)	≈3%	≈3%
All directors/officers combined	14.8M (5.6%)	84.2M (60.9%)	--	--

Dual-class structure. Class A shares carry 66.8% of total voting power. Class B shares carry 33.2%. Ghaffarian's 60.9% of Class B gives him effective veto power on any Class B matter, and combined with his Class A stake, control of the company. Classified (staggered) board with 3-year terms makes activist intervention difficult. Minority shareholders have limited governance influence.

Amazon's position. 24.9% economic interest via 65.8M Class A shares, acquired at $14.54/unit through warrant exercise in March 2026 (chose equity over cash -- a bullish signal). At $35.98, Amazon is sitting on 147% gain. Amazon is both equity investor and anchor customer. The alignment is structural but Amazon's contract terms (MFN, queue priority, efficiency sharing, ROFR) ensure that the economic surplus flows to Amazon, not XE. Amazon holds optionality; XE holds obligation.

Financial sponsors. Ares Management (26.2% Class B, 2 board seats via Kaplan and Satin -- see below). Ken Griffin / Citadel (6.1% Class A via XERC Holdings). Jane Street (7.9% Class B). Segra Capital (5.3% Class A). These are sophisticated institutional investors. Ares, Jane Street, and other financial sponsors will want to monetize positions -- their business model is invest, build, exit. This matters for lock-up expiration dynamics.

Board of Directors

Member	Role	Background	Independent?
J. Clay Sell	CEO, Chair	Former Deputy Secretary of Energy (Bush admin). Renewables development post-DOE.	NOT independent
Dr. Kamal Ghaffarian	Founder	Serial entrepreneur: SGT (now KBR subsidiary), Intuitive Machines (LUNR). Controls 60.9% voting.	NOT independent
David B. Kaplan	Director	Co-founder of Ares Management. Former Apollo Management. PE/alt assets.	NOT independent (Ares)
Allyson Satin	Director	Ares partner. Former COO of Ares Acquisition Corps I & II.	NOT independent (Ares)
Christopher F. Ginther	Director	Former EVP at Ontario Power Generation (2012-2024). Nuclear expertise.	Independent
Michael J. Wallace	Director	Nuclear industry veteran.	Independent
Kathleen W. Hyle	Director	Audit committee financial expert, chair.	Independent
Gregory J. Goff	Director	Former CEO Andeavor. Former VP Marathon Petroleum. Ex-Exxon board. ConocoPhillips.	Independent
Edward Sonnenschein	Director	Ares-connected.	Likely NOT independent

Assessment: 4 of 9 directors are not independent (Sell, Ghaffarian, Kaplan, Satin). Ares has 2 seats for 26% Class B ownership. Nuclear expertise is present (Ginther from OPG with 12 years in Canadian nuclear, Wallace). Energy industry representation is present (Goff from Andeavor/Marathon). But founder + financial sponsor control means the board is not a meaningful check on management.

Executive Compensation

Executive	Base Salary	Bonus	Stock Awards	Total	% Equity
J. Clay Sell (CEO)	$612K	$584K	$9.2M	$10.5M	88%
Daniel Gross (CFO)	$550K	$0	$5.2M	$5.7M	91%
Dragan Popovic (COO)	$84K*	$134K	$4.4M	$4.7M	95%

*Popovic started October 2025 -- base salary prorated.

Base salaries are modest for a $9.5B market cap company (CEO $612K). Compensation is heavily equity-weighted (88-95% stock awards), which aligns management with share price performance. Bonuses are discretionary, not formula-based -- less transparent than metric-driven incentive plans. No disclosed performance metrics tied to specific milestones (XE has reduced disclosure obligations as an Emerging Growth Company). The COO hire in October 2025 signals operational ramp for the commercialization phase.

Dilution Waterfall

Source	Additional Shares	% of Post-IPO Float (≈264M)
Class B convertible to Class A (at will)	131.3M	+50%
2026 Equity Incentive Plan	45.5M	+17%
2026 ESPP (Employee Stock Purchase Plan)	9.1M	+3%
IPO RSU/option grants	9.4M (subset of above)	Vesting schedule
Total potential dilution	≈186M shares	≈70%

Fully diluted share count: 395M+ shares. At $35.98, fully diluted market cap is approximately $14.2B -- 50% higher than the $9.5B headline figure. The $14.2B number is the correct basis for valuation, not the basic share count.

Up-C corporate structure. XE uses an umbrella partnership-C corporation (Up-C) structure for tax efficiency. Continuing equity owners (pre-IPO holders including Ghaffarian, Ares, and others) hold Common Units in the operating partnership that can be exchanged for Class A common stock at any time. This exchange mechanism means the dilution waterfall is not hypothetical -- it is a standing option that pre-IPO holders can exercise whenever they choose.

Lock-up expiration: approximately October 20, 2026. 180 days from IPO pricing (April 23, 2026). Approximately 131M Class B shares (convertible to Class A) plus pre-IPO Class A holders become saleable. IPO-directed shares (to employees and directors) were NOT subject to lock-up, except for directors and officers specifically. Lock-up wall represents approximately 50% additional float hitting the market.

Who will sell at lock-up expiry:

• Ares Management (26.2% Class B): Financial sponsor. Their business model is invest, build, exit. They will trim. They have 2 board seats to manage optics, but they will sell.
• Jane Street (7.9% Class B): Proprietary trading firm. Not a long-term strategic holder. Likely to sell.
• Amazon (24.9% Class A): Strategic holder at $14.54 cost basis (147% gain). Probably does NOT sell -- the investment is tied to the power procurement strategy. But the overhang matters.
• Ghaffarian (60.9% Class B): Founder. Controls the company. Unlikely to sell. But the market does not know this until lock-up passes without selling.

Tax Receivable Agreement (TRA). XE must pay 85% of certain tax savings realized (or deemed realized) to pre-IPO holders. The TRA includes an early termination provision: if XE terminates the agreement, it must pay a lump sum based on expected future tax savings. At a $17.50 share price, this liability was estimated at approximately $439M. At the current $35.98 share price, the liability is substantially higher. This is a meaningful contingent liability that transfers economic value from public shareholders to pre-IPO holders.

Related Party Transactions

1. Ghaffarian entities: Provided credit support (Bank of New York credit facility), received Class B units as fees. All settled by end of FY2024.
2. Amazon: Equity investor, warrant holder, and customer with MFN pricing, queue rights, efficiency sharing, and ROFR. Related person (>5% holder).
3. Tax Receivable Agreement: As described above -- 85% of tax savings to pre-IPO holders, with substantial early termination liability.

---

BETA -- Factor Profile

Regression: Not Possible

Two days of trading data. No regression can be run. Factor loadings are structural expectations based on peer analysis and business model characteristics, not empirical measurements.

Expected Factor Loadings

Factor	Expected Beta	Expected % Variance	Edge?
Nuclear SMR thematic	1.5-2.5	30-40%	No -- consensus trade, 15x oversubscribed
AI/datacenter power demand	0.5-1.0	10-20%	No -- macro narrative
Market (SPY)	1.0-1.5	10-20%	No
Growth/momentum style	High	10-15%	No -- 101x revenue, +56% in 2 days
Idiosyncratic	--	15-30%	Not at current information levels

Expected idiosyncratic variance share: 20-35%. This fails the 75% target. XE is a thematic trade, not a stock-picking opportunity. Returns will be driven primarily by the nuclear SMR narrative, AI power demand sentiment, and broad market risk appetite. Stock-specific events (NRC decisions, customer milestones, HALEU supply) matter but are secondary to whether the market wants nuclear exposure.

Why Peer %Idio Is Misleading

OKLO shows 99.2% idiosyncratic variance. SMR shows 96.7%. NNE shows 90.1%. These figures appear to satisfy the 75% idio target but are artifacts of pre-revenue binary event variance:

In pre-commercial companies, idiosyncratic variance is dominated by company-specific binary events (NRC decisions, customer announcements, trial results). These events create large single-day moves that swamp any factor correlation in a short data window. The measured "idio" is really "large unexplained move" -- it does not mean the stock is independent of the nuclear thematic.

On days when the nuclear narrative moves broadly (policy announcements, peer catalysts, AI power demand news), these names move together. The cross-sectional correlation is hidden by the within-stock event-driven noise.

BWXT ($22B, $2.6B revenue, established nuclear components manufacturer) shows 40% idiosyncratic variance. This is the structural proxy for what "real nuclear" looks like once you have commercial revenue. The nuclear thematic dominates. XE will converge toward this as it matures.

Options Infrastructure

No options chain exists for XE as of April 27, 2026 (Day 2 IPO). Options typically begin trading 3-5 business days after IPO (OCC/CBOE scheduling). Expected listing late April or early May 2026.

What no options chain means:

• No mechanical price support from dealer hedging. No put walls creating buying pressure on dips. No gamma pinning at any strike.
• No mechanical price resistance from call walls. No ceiling on upside from dealer selling.
• No extractable market-implied probability distribution. Cannot calculate risk-neutral P or derive market expectations for any outcome.
• Pure directional flow drives price -- IPO momentum buyers, ARK accumulation, thematic rotation.
• The first real pullback will be faster and deeper than in a name with established options infrastructure, because there are no shock absorbers.

Peer options context:

• OKLO ATM implied volatility: 100-118% annualized depending on expiry
• SMR ATM implied volatility: 118-130% annualized
• Expect XE to open at 120-150% ATM IV -- pricing roughly $15/month of expected movement in either direction

OKLO's Jan 2027 chain (262 days, structural proxy for XE's long-dated options when they list):

• 10,276 puts at $2 strike (literal wipeout insurance on a $76 stock)
• 8,115 puts at $20 strike (distress insurance)
• 12,775 calls at $150 strike (upside speculation)
• Market-implied P(OKLO > $55 in 9 months) = 80%. P(OKLO > $37) = 91%.
• 20% probability of -27%+ drawdown. 9% probability of -51%+ drawdown.
• Call IV exceeds put IV by 5-7% -- upside speculation exceeds downside hedging. Bullish skew reflects retail call buying.
• Max pain at $60 vs current $76 -- options market expects mean-reversion over 9 months

SMR peers (OKLO, SMR) carry 19-24% short interest. The nuclear SMR thematic is heavily contested.

Lock-Up Timing via Options Framework

When XE's options chain lists (~late April / early May 2026), the critical signals to watch:

Where institutional put OI concentrates = first mechanical floor. IPO allocators will hedge their positions. If heavy put OI forms at $25-30 (25-30% below current), dealers who sold those puts will delta-hedge by buying stock on dips to those levels, creating mechanical support.

September/October expiry positioning = lock-up intelligence.

• Scenario A: Heavy put OI at $25-30 in Sep/Oct expiries → institutional holders hedging through the lock-up event → dealers create a floor → lock-up selling is absorbed → less interesting as a short
• Scenario B: Sparse put OI in Sep/Oct expiries → nobody hedging → no mechanical floor through lock-up → if financial sponsors sell into thin infrastructure → cliff risk, downside -30-40%

What to monitor starting August 2026:

1. Sep/Oct put OI at $25, $28, $30 -- is a floor forming?
2. Sep/Oct put/call ratio -- >1.5 = heavy hedging
3. IV term structure -- inversion around October expiry = market pricing the lock-up event
4. Short borrow rate -- if borrow opens at <5% annualized, shorts can express the view

---

DELTA -- Expectations Gap

No analyst coverage. No consensus estimates. No forward multiples. No price targets. Day 2 of a 15x oversubscribed IPO with zero sell-side coverage initiated. Gaps are derived from reverse-DCF against S-1 primary source data.

What the Price Implies

EV calculation:

• Basic: $9.5B market cap - $1.15B pro forma cash = $8.35B EV
• Fully diluted: $14.2B market cap - $1.15B cash = $13.05B EV

Reverse-DCF (12% WACC, 10-year horizon, 20x terminal EBITDA, 40% terminal margin):

Basic EV ($8.35B):
  Terminal EV needed (2036) = ($8.35B + $2B cumulative burn) x (1.12)^10
                            = $10.35B x 3.106 = $32.1B
  At 20x terminal EBITDA:    $32.1B / 20 = $1.61B EBITDA by 2036
  At 40% terminal margin:    $1.61B / 0.40 = $4.0B revenue by 2036

Fully Diluted EV ($13.05B):
  Terminal EV needed (2036) = ($13.05B + $2B burn) x (1.12)^10
                            = $15.05B x 3.106 = $46.7B
  At 20x terminal EBITDA:    $46.7B / 20 = $2.34B EBITDA by 2036
  At 40% terminal margin:    $2.34B / 0.40 = $5.9B revenue by 2036

Sensitivity to terminal assumptions:

Scenario	Terminal Multiple	EBITDA Margin	Implied 2036 Revenue (Basic)	Implied 2036 Revenue (FD)
Bull	25x	45%	$2.9B	$4.2B
Base	20x	40%	$4.0B	$5.9B
Bear	15x	30%	$7.1B	$10.4B

What this means in reactor terms: At estimated $300M revenue per 4-pack deployment, the base case implies 11-17 four-packs deploying per year by 2036. The stated pipeline (144 reactors over 8-10 years) delivers 3.6-4.5 four-packs per year. The price implies 3-5x the stated pipeline's deployment rate. It requires massive TAM expansion beyond current customers.

Real options decomposition:

Pipeline	Reactors	Estimated Unrisked Value	Implied Conversion P	Risk-Adjusted Value
Dow (FOAK)	4	$0.5-1.0B	65-75%	$0.4-0.75B
Amazon Phase 1	4-12	$0.5-1.5B	50-60%	$0.3-0.9B
Amazon Full (5+ GWe)	62+	$5-10B	25-35%	$1.5-3.5B
Centrica (6 GWe)	76	$4-8B	15-25%	$0.8-2.0B
OPG/Canada	TBD	$0.5-1.0B	15-25%	$0.1-0.25B
TAM expansion	TBD	$5-20B	10-20%	$1.0-4.0B
Third-party fuel sales	N/A	$0.5-2.0B	20-30%	$0.1-0.6B
XENITH/defense	N/A	$0.2-0.5B	10-15%	$0.02-0.075B
Sum				$4.2-12.1B

Basic EV ($8.35B) sits in the middle-to-upper range of this distribution. The market prices high conversion probability on Dow + Amazon Phase 1, moderate conversion on the full Amazon pipeline, some value for Centrica + TAM expansion, and near-certainty that the technology works and NRC approves.

DELTA-1: Pipeline Conversion

	Price-implied (x*)	Research finding (x)	Gap (Delta)
Dow conversion P	65-75%	55-65%	-10%
Amazon full exercise (5 GWe)	30-35%	15-25%	-10 to -15%
Centrica binding agreement	15-25%	5-15%	-10%

Evidence:

• Dow can terminate the MPDA and CCA "at any time for convenience without regard for our performance" (S-1, p.28, q=0.95). This is not termination-for-cause. Dow can walk away for any reason at any stage.
• Amazon holds options for >5 GWe with first-priority queue slots 2031-2039, MFN pricing, efficiency sharing, and ROFR. These are options, NOT obligations. Amazon has no contractual commitment to purchase any reactors (S-1, p.29, q=0.95).
• Centrica JDA is explicitly non-binding (S-1, p.29, q=0.95). UK regulatory pathway (ONR) is separate from NRC. Mid-2030s timeline gives Centrica multiple exit ramps.
• ARDP funding period expires before Dow construction completes. Post-2031 costs fall entirely on Dow (S-1, p.28+31, q=0.95).
• Dow FY2025 services revenue declined $19.9M YoY -- work slowed after CPA submission. Natural lull, but also reflects the long gap between licensing and construction.

What closes this gap: Dow makes a binding FID (final investment decision). Amazon converts options to purchase commitments. NRC CPA approval (Q1 2027) materially de-risks the Dow timeline and triggers construction. A binding Amazon order would be the single most valuable catalyst for pipeline conversion.

DELTA-2: Timeline to Commercialization

	Price-implied (x*)	Research finding (x)	Gap (Delta)
First reactor COD	2031-2032	2032-2035	-1 to -3 years
NRC CPA approval	On schedule (Q1 2027)	Q1 2027 to 2028+	0 to -1 year
TX-1 operational	H1 2028	H1 2028 to 2029	0 to -1 year

Evidence:

• Every nuclear FOAK in history has experienced delays. Vogtle 3&4: 7 years late, $16B per unit vs $14B projected. PBMR: cancelled after $1.5B without building. China HTR-PM: program launched 2001, full power 2023 (22 years from concept to commercial operation).
• ARDP max performance period is 10 years from February 2021 = 2031. The Dow project's construction timeline extends beyond this. The gap between ARDP expiry and Dow COD ("early 2030s") creates a structural funding cliff.
• NRC has delayed construction permits before. The 18-month timeline for the CPA review is ambitious by historical standards, even with the "one of the shortest ever" characterization.
• TX-1 is under construction with 60% design review complete and Clark Construction in vertical build since September 2025. This specific milestone is the most likely to be met on schedule.

What closes this gap: NRC CPA approved on schedule (Q1 2027). TX-1 completes on schedule (H1 2028). These two milestones are the first falsifiable near-term tests. If both hit, timeline gap narrows materially. If either misses, the nuclear base rate reasserts.

DELTA-3: Unit Economics (Unknowable)

	Price-implied (x*)	Research finding (x)	Gap (Delta)
Terminal EBITDA margin	30-45% (implied)	Not disclosed	Unknowable
Technology fee per reactor	$100-200M (implied)	Not disclosed	Unknowable
FOAK vs NOAK cost	NOAK economics (implied)	FOAK only for first decade	Negative

Evidence:

• No per-reactor revenue, technology fee, or margin figure appears anywhere in the S-1. Not in the Business section, not in MD&A, not in pro forma financials.
• Management explicitly warns: "Our illustrative capacity figures and unit economics in this prospectus are estimates based on numerous assumptions (including technology fees, services, and fuel pricing); actual results may differ materially, including lower pre- and post-COD revenues and margins" (S-1 Risk Factors, q=0.95).
• Amazon's MFN pricing, efficiency sharing, and queue priority terms will compress whatever margin exists on XE's largest potential customer account. XE must offer Amazon at least as favorable terms as any other customer, and must share cost efficiency gains with Amazon. This structurally caps upside on 62+ reactors worth of revenue.
• XE does not carry product performance insurance on the Xe-100 reactor. If the reactor underperforms specifications, XE bears the cost (S-1 Risk Factors, q=0.95).

This is the most dangerous gap -- not because it is the largest measurable negative, but because it is unmeasurable. The market is pricing $8-13B of enterprise value on a business model whose per-unit profitability has never been disclosed, never been tested, and never been demonstrated. You cannot calculate edge on a quantity you cannot observe.

What closes this gap: Management discloses unit economics in future earnings calls or SEC filings. As an EGC, XE has reduced disclosure obligations. This gap may persist for years.

DELTA-4: HALEU Supply

	Price-implied (x*)	Research finding (x)	Gap (Delta)
HALEU availability by 2030	Sufficient for pipeline	≈6 MTU/yr (Centrus) + 7.6 MTU DOE allocation	Negative
TX-1 throughput at steady state	5 MTU/yr achievable	Requires more HALEU than current US production	Negative
TX-2 buildable by mid-2030s	25 MTU/yr supply exists	Supply chain not at this scale globally	Negative

Evidence:

• No commercial-scale HALEU supply exists outside Russia and China (S-1 Risk Factors, q=0.90).
• DOE allocated first tranche of 4 MTU to XE; total HALEU Availability Program provides ≈7.6 MTU (enough for first Dow plant initial load only) (S-1, pp.114-115, q=0.95).
• Centrus targeting 6 MTU/yr by Q1 2029 from ≈1 MTU/yr current pilot (Centrus public filings, q=0.85).
• DOE awarded additional $2.7B for domestic enrichment services (January 2026).
• XE enriches at 15.5% HALEU, requiring ≈3x the separative work units of conventional <5% LEU.
• TX-1 needs 5 MTU/yr. TX-2 needs 20 MTU/yr. Combined: 25 MTU/yr. Total projected non-Russian/Chinese HALEU supply by early 2030s: 15-25 MTU/yr globally, shared across multiple customers (XE, Kairos, Oklo, TerraPower, others).

This is a physics constraint, not a business constraint. Centrifuge cascades take years to design, build, license, and commission. Congress can appropriate money, but cannot accelerate the laws of enrichment.

What closes this gap: Centrus, Urenco, or new entrants scale HALEU production faster than current targets. New DOE enrichment programs deliver capacity ahead of schedule. A breakthrough in alternative enrichment technology (laser enrichment, etc.) changes the supply curve. All of these have multi-year lead times.

DELTA-5: Cash Burn and Dilution

	Price-implied (x*)	Research finding (x)	Gap (Delta)
Market cap basis	≈264M basic shares ($9.5B)	≈395M+ FD shares ($14.2B)	-33% EV underestimate
Additional raises needed	Minimal (IPO funded)	$1-2B+ before profitability	Negative
Annual burn trajectory	Stable ≈$200M	Doubling: $95M → $192M → $300M+	Negative

Evidence:

• S-1 capitalization table shows 131.3M Class B shares convertible to Class A at will + 54.6M equity plan shares = ≈186M additional shares (≈70% dilution). Fully diluted cap is $14.2B (S-1, q=0.95).
• Operating cash burn accelerated 56% YoY ($96M → $150M). Total net burn doubled ($95M → $192M). Pro forma public company costs add $47M/yr. Burn trajectory: $250-340M in FY2026E.
• Management: "our continued existence is dependent upon our ability to obtain additional capital" (S-1, p.106, q=0.95). This is as explicit as a company can be about future dilution.
• Lock-up expiration (~October 2026) releases ≈131M shares. Financial sponsors (Ares, Jane Street) are likely sellers.
• TRA early termination liability of $439M+ further encumbers equity value.

What closes this gap: Burn rate stabilizes (unlikely given TX-1 construction ramp and public company costs). Commercial revenue begins earlier than expected (early 2030s at best). A strategic investor provides non-dilutive funding (DOE grants, project finance, etc.). None of these appear likely in the near term.

DELTA-6: Competitive Moat

	Price-implied (x*)	Research finding (x)	Gap (Delta)
IP exclusivity	Strong, proprietary	Constrained by Bayh-Dole march-in	Slightly negative
International competition	Limited	China operating HTGR + TRISO facility	Slightly negative
Peer differentiation	XE best-positioned SMR	NuScale has NRC design cert (XE doesn't yet)	Mixed

Evidence:

• DOE march-in rights under Bayh-Dole are disclosed and real (S-1, p.136, q=0.95). Government can force-license ARDP-funded IP.
• China HTR-PM at Shidao Bay is the world's first commercial pebble-bed HTGR, full power December 2023 (S-1 Risk Factors + public record, q=0.90). China is marketing HTGR technology internationally.
• NuScale (SMR) received NRC Standard Design Approval in January 2023. XE has not yet achieved design certification -- only a construction permit application under review. NuScale is further along the NRC pathway for the specific reactor design, though its anchor project failed.

What closes this gap: XE achieves NRC Standard Design Approval (enabling broader deployment without per-customer CPAs). China's international marketing fails to gain traction. NuScale or other competitors fail to secure replacement customers.

DELTA-7: Political and Regulatory

	Price-implied (x*)	Research finding (x)	Gap (Delta)
ARDP funding continuity	Secure through completion	Budget period through Aug 2026, extensions at DOE discretion	Slightly negative
Political support durability	Bipartisan, durable	Currently favorable but ARDP dependent on appropriations	~Neutral
NRC regulatory pace	Faster than historical	18-month CPA review is aggressive; NRC has delayed before	Slightly negative

Evidence:

• ARDP budget period runs through August 2026. Extensions are at DOE discretion. Max performance period: 10 years from February 2021 = 2031 (S-1, p.31, q=0.95).
• Nuclear enjoys the strongest bipartisan political support in 40 years. May 2025 executive orders favorable to nuclear. Multiple Congressional appropriations for HALEU and advanced reactors.
• NRC's 18-month CPA timeline is the shortest ever given for this application type -- a process signal of regulatory support.
• Government can cancel ARDP contract at any time without substantive penalty (S-1, p.136, q=0.95).

What closes this gap: ARDP budget period extended beyond August 2026 (likely). Bipartisan nuclear support continues through future Congressional cycles. NRC CPA decision arrives on schedule. All of these are currently probable but not guaranteed.

Gap Summary

Rank	Gap	Magnitude	Direction	Source Quality (q)
1	Unit economics (Delta-3)	Unknowable	Cannot assess	0.95 (S-1 explicitly opaque)
2	Cash burn / dilution (Delta-5)	Large	Negative	0.93
3	HALEU supply (Delta-4)	Large	Negative	0.85
4	Pipeline conversion (Delta-1)	Large	Negative	0.80
5	Competitive moat (Delta-6)	Moderate	Negative	0.85
6	Timeline (Delta-2)	Moderate	Negative	0.78
7	Political/regulatory (Delta-7)	Small	Negative	0.73

Every measurable gap is negative. No dimension was identified where primary sources suggest the market is too pessimistic. The market is pricing XE as a high-probability commercializer of SMR technology at scale, and on every measurable dimension, the S-1 primary source data suggests reality is less favorable than what the price implies.

---

Key Risks

Existential:

1. No commercial reactor has been delivered. Zero revenue from the core business model. Zero Xe-100 reactors built, ever, anywhere. The technology class works (China HTR-PM), but the specific design does not have a physical reference plant.
2. Continued existence depends on additional capital. Management's words, S-1, p.106. Not a standard risk factor boilerplate -- the company explicitly states it cannot continue without future fundraising. Future dilutive equity raises are near-certain.
3. HALEU supply does not exist at required scale. TX-1 needs 5 MTU/yr. US produces ≈1 MTU/yr. Even the most optimistic 2029 supply targets (6 MTU/yr from Centrus) barely cover one facility. The pipeline cannot scale without solving this physics constraint.
4. Dow can terminate the anchor project at any time for convenience. The MPDA and CCA are terminable without cause. Dow's decarbonization strategy provides rationale, but Dow's capital allocation priorities can shift. No FID has been made.

Material: 5. Amazon monopsony terms. MFN pricing, efficiency sharing, queue priority, and ROFR constrain XE's margins and capacity allocation for its largest potential customer. These terms ensure that as XE's costs decline, Amazon captures the surplus. 6. ARDP funding cliff. The cost-share period expires before Dow construction completes. Post-ARDP costs (≈2031+) fall entirely on Dow. $662M in remaining ARDP funding may not be sufficient for the full project. 7. 70% dilution waterfall. 131.3M Class B shares + 54.6M equity plan shares = ≈186M additional shares. Fully diluted cap is $14.2B, not $9.5B. Lock-up expiration (~October 2026) adds ≈50% to float. 8. No product performance insurance. XE does not carry insurance covering Xe-100 reactor performance. If the reactor underperforms specifications, XE bears the cost. 9. Revenue recognition creates a mirage. Cost-to-cost method on government contracts means spending = "revenue." As XE ramps spending, revenue appears to grow, but the economic substance is expenditure on a cost-share contract, not commercial traction. 10. FOAK cost unknowable. Vogtle cost $16B per unit, 7 years late. PBMR was cancelled after $1.5B without building anything. NOAK cost reductions are theoretical with zero data points. The S-1 provides no basis for estimating FOAK reactor construction costs.

Structural: 11. DOE Bayh-Dole march-in rights on ARDP-funded IP. Government can force-license reactor design to third parties. The IP moat is conditional on government forbearance. 12. China operates a commercial HTGR and TRISO facility and is marketing internationally. In non-allied markets, China has first-mover advantage with demonstrated operating experience. 13. Governance: 4 of 9 board members not independent. Founder controls 60.9% voting power. Dual-class structure with classified board. Minority shareholders have limited recourse. 14. Key person risk. 916 specialized employees. Nuclear engineering talent is scarce. Former PBMR scientists are core to the technology team. Loss of key personnel could materially delay the program.

---

What to Watch

Catalyst Calendar

Date	Event	Significance
Late Apr / Early May 2026	Options chain lists	First extractable market-implied distribution; first mechanical price floors and ceilings from dealer hedging
May 2026	TX-1 90% design review begins	Execution signal on fuel facility construction. If on schedule: confirms construction timeline.
Aug 2026	ARDP budget period expires	Extension needed. At DOE's discretion. Non-renewal would be severely negative.
~Oct 20, 2026	Lock-up expiration	≈131M shares become saleable. ≈50% additional float. Financial sponsors (Ares, Jane Street) likely to trim. Watch for put OI formation at $25-30 as hedge signal.
End 2026	Amazon/Energy NW CPA submission to NRC	Second NRC filing. Validates pipeline progression beyond Dow.
Q1 2027	NRC CPA decision (Dow Seadrift)	BINARY CATALYST. Approval materially de-risks timeline and triggers construction. Denial or multi-year delay is near-existential for the anchor project.
H1 2028	TX-1 fuel facility target operations	First real execution test of the manufacturing business. Can XE produce TRISO-X fuel at commercial scale?
2028	Amazon/Energy NW CPA decision	Second regulatory gate. If approved, Amazon pipeline de-risks.
Early 2030s	Dow first reactor COD	First commercial revenue. Validates the entire business model. Activates the fuel annuity.

Strengthening Signals

• NRC CPA approved on schedule (Q1 2027)
• Dow makes binding FID with disclosed project cost and timeline
• Amazon converts options to binding purchase commitments
• HALEU supply announcements from Centrus or new entrants exceeding current targets
• TX-1 construction milestones met on schedule (90% design review May 2026, completion 2027)
• Unit economics disclosed showing attractive margins (>30% EBITDA at scale)
• Additional customer announcements with binding terms
• Competitor failures (NuScale fails to find replacement customer, Oklo NRC resubmission delayed)

Weakening Signals

• NRC CPA denied or delayed >12 months past Q1 2027 target
• Dow terminates MPDA/CCA for convenience
• ARDP funding lapses without extension past August 2026
• HALEU supply announcements showing <10 MTU/yr available by 2030
• TX-1 construction delays pushing commissioning past 2029
• Additional dilutive equity raise at significant discount to market
• Competitor FOAK reactor completes before XE (Kairos/TerraPower)
• Amazon reduces or cancels power procurement with XE in favor of alternatives
• China HTGR export wins in markets XE is targeting (UK, Middle East)
• TRISO-X fuel qualification tests reveal unexpected failure modes

---

Steelman Bear Case

The strongest argument against XE at $14.2B fully diluted is not that the technology is fake -- it is real, with 60 years of heritage, demonstrated physics, and a working Chinese reference plant. The bear case is this:

The price assumes commercial execution that has never occurred in this sector at anything close to projected cost or timeline, on a business model whose economics have never been disclosed, funded by a capital structure that requires continuous dilution, constrained by a fuel supply chain that does not exist at the required scale, with the anchor customer retaining the explicit right to walk away at any time for any reason.

The specifics:

1. Nuclear FOAK base rate is ≈0%. Vogtle: 7 years late, $16B/unit. PBMR (XE's direct technology ancestor): cancelled after $1.5B without building a reactor. NuScale Idaho: cancelled after NRC design certification. China HTR-PM: 22 years from concept to full power. The base rate for on-time, on-budget nuclear FOAK delivery is approximately zero. XE is asking investors to believe it will be the exception.

2. Unit economics are a black box. The market is pricing $8-13B of enterprise value for a business model that has never disclosed what it earns per reactor. The S-1 explicitly warns that "illustrative unit economics" may be materially different from reality, including "lower revenues and margins." Amazon's MFN + efficiency sharing terms structurally cap margins on the largest customer. Investors are buying blind.

3. HALEU constrains everything. Even if every NRC approval arrives on time, every customer commits, and every reactor is designed perfectly -- you cannot fuel reactors with uranium that does not exist. US HALEU production is ≈1 MTU/yr. XE needs 25+ MTU/yr at full scale. This is a physics bottleneck that Congressional appropriations cannot wish away.

4. The pipeline is options, not orders. 144 reactors, 11+ GWe -- all contingent. Dow: terminable for convenience. Amazon: options not obligations with monopsony terms. Centrica: non-binding JDA. Zero binding purchase commitments in the entire pipeline. Pipeline does not equal backlog.

5. Capital structure guarantees dilution. Management says they need more capital. Burn is doubling. $1.15B lasts 3.8 years at current trajectory. 70% dilution waterfall from Class B conversion + equity plans. The fully diluted cap is $14.2B, not the $9.5B headline.

The bull response -- that modular construction, factory fabrication, Korean supply chain partners (who delivered Barakah on schedule), DOE backing, Amazon's strategic commitment, and bipartisan political support change the nuclear FOAK dynamic -- is not dismissible. The Korean supply chain (Doosan, KHNP) IS genuinely strong. SGL Carbon IS producing graphite. TX-1 IS under construction with an SNM license in hand. The safety physics IS real and NRC-acknowledged. The fuel annuity model IS genuinely attractive if reactors get built.

But "genuinely attractive if" is the operative phrase. The first falsifiable test is Q1 2027 (NRC CPA decision). Until then, the $14.2B valuation is a bet on the exception to the historical rule, with no near-term mechanism to validate or invalidate the thesis.

The bear case deserves engagement, not dismissal. The honest synthesis: both sides have merit. The price assumes the bull case.

Kill Criteria

This is coverage initiation, not a position. If a position were contemplated:

Thesis dies if:
- NRC CPA denied or delayed >12 months past Q1 2027 target → exit
- Dow terminates MPDA/CCA for convenience → exit
- HALEU supply announcements show <10 MTU/yr available by 2030 → exit
- Management raises capital at >25% discount to then-current price → exit
- TRISO-X fuel qualification tests fail → exit

Thesis strengthened if:
- NRC CPA approved on schedule (Q1 2027) → revisit at post-approval price
- Dow makes binding FID → pipeline conversion begins, add
- Post-lock-up washout to $20-25 → forced-seller opportunity, entry window
- TX-1 milestones met on schedule → manufacturing execution validated
- Unit economics disclosed showing >30% EBITDA margin at scale → add
- Amazon converts options to binding orders → add aggressively

Evidence

Evidence	Source	Credibility	LR
FY2025: services revenue $94.3M, grant income $14.8M, operating loss -$170.3M. Costs +24%. Revenue -9%	S-1/A 2026-04-20, pp.105-106	0.95	0.7
Revenue composition: DOE ARDP $89.2M (82% of total). Dow services declined $19.9M. Energy NW +$3.4M	S-1/A 2026-04-20, p.105	0.95	0.7
Revenue recognition: ASC 606 cost-to-cost input method on government contracts. Spending = revenue recognition	S-1/A 2026-04-20, p.109	0.95	0.8
Operating cash burn -$149.9M (+56% YoY). Gross capex -$117.2M (TX-1). Net burn ≈$192M (doubled)	S-1/A 2026-04-20, p.108 + CF statement	0.95	0.7
"Our continued existence is dependent upon our ability to obtain additional capital"	S-1/A 2026-04-20, p.106	0.95	0.7
Pipeline 11+ GWe, 144 reactors -- all contingent. Zero binding purchase commitments for reactors	S-1/A 2026-04-20, Risk Factors + Business	0.95	1.0
Dow MPDA/CCA: terminable "at any time for convenience without regard for our performance"	S-1/A 2026-04-20, p.28	0.95	0.6
Amazon contract: MFN pricing + first-priority queue slots 2031-2039 + efficiency sharing + ROFR. Options not obligations	S-1/A 2026-04-20, p.29	0.95	0.8
Centrica JDA: explicitly non-binding. UK regulatory pathway separate from NRC. Mid-2030s timeline	S-1/A 2026-04-20, p.29	0.95	0.7
HALEU supply: DOE allocated 7.6 MTU total (one plant). No commercial-scale supply outside Russia/China. 15.5% enrichment = ≈3x SWU vs LEU	S-1/A 2026-04-20, Risk Factors + pp.114-115	0.90	0.7
Centrus HALEU target: 6 MTU/yr by Q1 2029 from ≈1 MTU/yr current pilot production	Centrus public filings, DOE program data	0.85	0.7
"Illustrative unit economics... estimates based on numerous assumptions... may differ materially, including lower pre- and post-COD revenues and margins"	S-1/A 2026-04-20, Risk Factors	0.95	0.7
No product performance insurance on Xe-100 reactor. XE bears cost of underperformance	S-1/A 2026-04-20, Risk Factors	0.95	0.8
DOE retains Bayh-Dole march-in rights: can force-license ARDP-funded IP to third parties. Can cancel contract without penalty	S-1/A 2026-04-20, p.136	0.95	0.8
TX-1: 214K sq ft, 5 MTU/yr, SNM License received Feb 2026, Clark Construction vertical build since Sep 2025, 60% design review complete, 90% starting May 2026, DOE $150M tax credit (milestone-based)	S-1/A 2026-04-20, Business section	0.95	1.3
TX-2 planned adjacent, 25 MTU/yr, 44 reactors/yr capacity. No separate NRC license needed if same site	S-1/A 2026-04-20, Business section	0.95	1.2
Supply chain: Doosan Reservation Agreement (SMR fab facility, 34 RPVs globally). KHNP compact (30 nuclear plants built). SGL Carbon $100M+ graphite (production commenced). Curtiss-Wright preferred supplier.	S-1/A 2026-04-20, p.12	0.95	1.3
Amazon/Energy NW project: CPA submission by end 2026, construction H1 2028, COD early 2030s. Initial 320 MWe, potential 960 MWe. Energy NW owns Columbia Generating Station (1.2 GWe)	S-1/A 2026-04-20, Business section	0.95	1.2
Governance: Ghaffarian 60.9% Class B voting. CEO 88% equity comp ($10.5M total). Amazon 24.9% economic at $14.54 cost basis (147% gain). Ares 26.2% Class B + 2 board seats	S-1/A 2026-04-20, proxy/comp tables	0.95	1.0
Dilution waterfall: 131.3M Class B + 54.6M equity plans = ≈186M shares (≈70% of post-IPO float). FD cap ≈$14.2B	S-1/A 2026-04-20, capitalization table	0.95	0.7
TRA early termination liability ≈$439M at $17.50/share (higher at $35.98). 85% of tax savings to pre-IPO holders	S-1/A 2026-04-20, p.18	0.95	0.8
Lock-up: 180 days from April 23, 2026 (~October 20, 2026). ≈131M Class B + pre-IPO Class A become saleable. ≈50% additional float	S-1/A 2026-04-20, underwriting section	0.95	0.9
ARDP: $1.2B total commitment, $438M reimbursed, $662M remaining. Budget period through Aug 2026. Max 10-year period from Feb 2021 = 2031	S-1/A 2026-04-20, p.31	0.95	0.8
China HTR-PM at Shidao Bay: world's first commercial pebble-bed HTGR, 500 MWt (2x250 MWt), 210 MWe, full power Dec 2023. Marketing internationally	S-1/A Risk Factors + public record	0.90	0.8
South Africa PBMR: cancelled 2010 after ≈$1.5B, never built. XE hired PBMR scientists (van Staden, Mulder) 2012-14. Direct technology lineage	Public record, S-1/A management bios	0.85	0.8
Technology heritage: Peach Bottom (1966), Dragon (1966), AVR (1967-88), THTR-300 (1985-89, shut down for pebble breakage)	Public nuclear history	0.90	1.0
Xe-100 passive safety: negative temperature coefficient + low power density + TRISO SiC containment. 400m EPZ vs 16km for LWR. Online refueling, 95%+ capacity factor target, 60-year design life	S-1/A Business section + established HTGR physics	0.93	1.1
OKLO 18.8% short interest, SMR 23.5% short interest. Nuclear SMR peers heavily contested	yfinance market data, April 27, 2026	0.90	1.0
No options chain for XE (Day 2 IPO). No mechanical support/resistance. Peer ATM IV 100-120%. Expected XE IV 120-150%	yfinance options data, April 27, 2026	0.95	1.0
IPO: priced $23 (above $16-19 range), 15x oversubscribed, raised $1.02B. ARK bought $71M+. Day 2: $35.98 (+56% vs IPO)	S-1/A, market data, Grok	0.90	1.0
SG&A underlying growth ≈$60M (adjusted for $55.3M one-time warrant cost in FY2024): +$26.8M payroll, +$13.5M SBC, +$12.1M contractors, +$5.5M tech	S-1/A 2026-04-20, p.106	0.95	0.8
Pro forma public company costs: +$47M/yr ($17M comp + $30M SBC). Pro forma operating loss -$217M vs actual -$170M	S-1/A 2026-04-20, pro forma financials	0.95	0.8